Psychiatry and Neurology, Neurology · Weslaco, TX
NPI
1689089468
Since 2014
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1402 E 8th St Ste 1
Weslaco, TX, 78596
Phone (956) 332-3400
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
1,078 services
Medicare patients, 2024
107
Average age 66
Drug cost, 2024
$3.5M
4,192 prescriptions
Company payments, 2025
$4,210
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karylsa Torres Gomez was code 99214 (office e&m - established), 103 times for 54 patients. In total Karylsa Torres Gomez billed 1,078 services in 15 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 103 | 54 | $73.88 | $7,610 |
| 99215 Office E&M - Established | Office | 72 | 36 | $125.36 | $9,026 |
| 95812 Neurologic | Office | 16 | 16 | $235.79 | $3,773 |
| 95816 Neurologic | Office | 12 | 12 | $265.97 | $3,192 |
| 95819 Neurologic | Facility | 11 | 11 | $38.71 | $426 |
By year: 2022 $50K for 2,332 services; 2023 $25K for 1,065 services; 2024 $32K for 1,078 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 25 | 22 | $8.40 | $210 |
Medicare prescription drug claims, 2024
In 2024, the drug Karylsa Torres Gomez prescribed most often to Medicare patients was Levetiracetam, with 313 prescriptions and refills. In total Karylsa Torres Gomez wrote 4,192 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 313 | 569 | 72 | $18K |
| Lacosamide Generic | 303 | 335 | 36 | $43K |
| Clobazam Generic | 230 | 244 | 29 | $35K |
| Lamotrigine Generic | 182 | 240 | 25 | $3,324 |
| Donepezil Hcl Generic | 167 | 250 | 42 | $865 |
| Xcopri Cenobamate | 166 | 176 | 21 | $191K |
| Zonisamide Generic | 114 | 157 | 20 | $3,051 |
| Memantine Hcl Generic | 112 | 185 | 31 | $1,975 |
| Briviact Brivaracetam | 111 | 111 | 13 | $164K |
| Primidone Generic | 105 | 147 | 18 | $1,481 |
| Clonazepam Generic | 104 | 105 | 22 | $1,369 |
| Epidiolex Cannabidiol (Cbd) | 100 | 100 | Under 11 | $747K |
| Topiramate Generic | 94 | 152 | 21 | $707 |
| Memantine Hcl Er Memantine Hcl | 82 | 122 | 15 | $5,012 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 81 | 171 | 22 | $2,301 |
Brand drugs: 1,073 claims; generic drugs: 3,072 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karylsa Torres Gomez $4,210 ($4,210 in general payments such as food, travel and fees) from 20 companies. The largest payer was UCB, Inc. with $2,063.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 39 | $2,063 |
| Abbvie Inc. ABBV | 28 | $303 |
| LivaNova USA, Inc. LIVN | 7 | $264 |
| Teva Pharmaceuticals USA, Inc. TEVA | 7 | $215 |
| Lundbeck LLC | 17 | $206 |
| Janssen Biotech, Inc. JNJ | 5 | $189 |
| Jazz Pharmaceuticals Inc. JAZZ | 9 | $159 |
| Pfizer Inc. PFE | 7 | $155 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $111 |
| SK Life Science, Inc. | 4 | $99.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.